Literature DB >> 18441006

Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups.

S J Chung1, D Kim, M J Park, Y S Kim, J S Kim, H C Jung, I S Song.   

Abstract

BACKGROUND: Obesity has been associated with reflux oesophagitis. However, the relationship between metabolic syndrome characterised by visceral obesity and reflux oesophagitis is unclear. AIM: To investigate whether metabolic syndrome or visceral obesity is a risk factor for reflux oesophagitis.
METHODS: A cross-sectional study of 7078 subjects undergoing upper endoscopy during health check-ups was conducted (3539 patients with reflux oesophagitis vs age- and sex-matched controls). We further analysed according to categories of visceral adipose tissue and subcutaneous adipose tissue area with 750 cases and age-, sex- and waist circumference-matched controls who underwent abdominal CT scan.
RESULTS: The prevalence of metabolic syndrome was higher in cases than controls (26.9% vs 18.5%, p<0.001). Multivariate analysis demonstrated that metabolic syndrome is associated with reflux oesophagitis (odds ratio (OR) = 1.42; 95% confidence interval (CI), 1.26 to 1.60). Among the individual components of metabolic syndrome, waist circumference (OR = 1.47; 95% CI, 1.30 to 1.65) and triglyceride (OR = 1.20; 95% CI, 1.05 to 1.36) independently increased the risk for reflux oesophagitis. On sub-analysis, cases showed higher mean visceral adipose tissue area (cm(2)) (136.1 (SD 57.8) vs 124.0 (SD 54.7), p<0.001) and subcutaneous adipose tissue area (cm(2)) (145.9 (SD 56.8) vs 133.5 (SD 50.7), p<0.001). However, only visceral adipose tissue area was an independent risk factor for reflux oesophagitis after adjusting for multiple confounders including smoking, alcohol, body mass index (BMI) and subcutaneous adipose tissue area (OR = 1.60; 95% CI, 1.03 to 2.48, lowest quartile vs highest quartile).
CONCLUSIONS: Metabolic syndrome was associated with reflux oesophagitis. Abdominal obesity, especially visceral obesity, was an important risk factor for reflux oesophagitis.

Entities:  

Mesh:

Year:  2008        PMID: 18441006     DOI: 10.1136/gut.2007.147090

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  89 in total

1.  Nonalcoholic fatty liver disease is associated with coronary artery calcification.

Authors:  Donghee Kim; Su-Yeon Choi; Eun Ha Park; Whal Lee; Jin Hwa Kang; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon; Sook Hyang Jeong; Dong Ho Lee; Hyo-suk Lee; Joseph Larson; Terry M Therneau; W Ray Kim
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

Review 2.  Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Anamay N Sharma; Mohammad Hassan Murad; Navtej S Buttar; Hashem B El-Serag; David A Katzka; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-22       Impact factor: 11.382

3.  Metabolic syndrome is associated with erosive esophagitis.

Authors:  Jung-Ho Park; Dong-Il Park; Hong-Joo Kim; Yong-Kyun Cho; Chong-Il Sohn; Woo-Kyu Jeon; Byung-Ik Kim
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

4.  Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia.

Authors:  Song-Seng Loke; Kuender D Yang; Kuang-Den Chen; Jung-Fu Chen
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

5.  Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males.

Authors:  Toshiaki Gunji; Hajime Sato; Kimiko Iijima; Kazutoshi Fujibayashi; Mitsue Okumura; Noriko Sasabe; Akio Urabe; Nobuyuki Matsuhashi
Journal:  J Gastroenterol       Date:  2011-01-13       Impact factor: 7.527

Review 6.  Association between diabetes mellitus and gastroesophageal reflux disease: A meta-analysis.

Authors:  Xiao-Meng Sun; Jia-Cheng Tan; Ying Zhu; Lin Lin
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

7.  Abdominal Visceral Adipose Tissue is Associated with Myocardial Infarction in Patients with COPD.

Authors:  Alejandro A Diaz; Tom P Young; Sila Kurugol; Erick Eckbo; Nina Muralidhar; Joshua K Chapman; Gregory L Kinney; James C Ross; Raul San Jose Estepar; Rola Harmouche; Jennifer L Black-Shinn; Matthew Budoff; Russell P Bowler; John Hokanson; George R Washko
Journal:  Chronic Obstr Pulm Dis       Date:  2015

8.  The effect of Roux-en-Y gastric bypass on gastroesophageal reflux disease in morbidly obese Chinese patients.

Authors:  Chi-Ming Tai; Yi-Chia Lee; Ming-Shiang Wu; Chi-Yang Chang; Ching-Tai Lee; Chih-Kun Huang; Hsin-Chih Kuo; Jaw-Town Lin
Journal:  Obes Surg       Date:  2008-10-15       Impact factor: 4.129

9.  Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population.

Authors:  Jeong Yoon Yim; Donghee Kim; Seon Hee Lim; Min Jeong Park; Seung Ho Choi; Chang Hyun Lee; Sun Sin Kim; Sang-Heon Cho
Journal:  Diabetes Care       Date:  2010-09-15       Impact factor: 19.112

10.  Abdominal obesity as a risk factor for the development of erosive esophagitis in subjects with a normal esophago-gastric junction.

Authors:  Ja Seol Koo; Sang Woo Lee; Sun Min Park; Sung Woo Jung; Hyung Joon Yim; Jong Jae Park; Hoon Jai Chun; Hong Sik Lee; Jai Hyun Choi; Chang Duck Kim; Ho Sang Ryu
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.